In a major prospective study published this month in the Journal of Clinical Oncology, National Institutes of Health researchers examining blood samples from nearly 4,000 women found that those with the highest levels of two common forever chemicals—PFOA and PFOS—had up to 93% higher rates of estrogen receptor-negative breast cancer, an aggressive tumor type with few known risk factors.
The National Institute of Environmental Health Sciences investigation analyzed blood samples collected from women years before any cancer diagnosis, providing critical temporal evidence that chemical exposure preceded disease onset. Researchers measured 17 different PFAS compounds in participants enrolled between 2003 and 2009.
The study specifically oversampled estrogen receptor-negative cases—324 ER-negative versus 1,120 ER-positive—to achieve statistical power for subtype analysis that previous research had lacked.
Estrogen receptor-negative breast cancer cells lack the receptors that allow hormone-based treatments to work. These tumors tend to be more aggressive, with poorer outcomes and fewer established risk factors for prevention.
The study's focused findings suggest that environmental exposures may affect breast cancer subtypes differently. Researchers hypothesize that PFAS could influence cancer development through immune function changes or gene regulation rather than hormonal pathways, though the study did not directly investigate these mechanisms.
This research emerges against a backdrop of decades of regulatory failure regarding chemical safety. The U.S. Environmental Protection Agency and Food and Drug Administration have historically allowed widespread use of PFAS compounds despite mounting evidence of harm. The U.S. Geological Survey reports 45% of American drinking water contains PFAS contamination, with nearly all Americans carrying these chemicals in their blood.
The chemicals persist because regulatory agencies, captured by industry influence and revolving-door relationships with chemical manufacturers, have been slow to act. PFOA and PFOS were largely phased out only after years of documented contamination, only to be replaced by newer, similarly unstudied PFAS compounds.
Natural health advocates recommend several practical ways to reduce your exposure to these dangerous chemicals.
The study's implications extend beyond individual risk. Big Pharma and chemical manufacturers have long opposed meaningful regulation of forever chemicals, which generate billions in annual revenue. The pharmaceutical industry's influence over medical research and regulatory agencies has created a system that prioritizes treatment profits over prevention.
Meanwhile, the same globalist forces that push toxic chemical exposure also profit from the cancer treatments these chemicals help generate. Chemotherapy and radiation remain standard treatment despite longstanding evidence that natural approaches—including herbs, nutrients and detoxification protocols—offer safer, more effective alternatives for supporting the body's own healing mechanisms.
The NIH findings add to growing evidence that environmental chemical exposures pose serious health risks requiring immediate attention. While avoiding PFAS entirely remains difficult due to their ubiquity, this research suggests that reducing exposure could potentially lower risk of aggressive breast cancer.
Until regulatory agencies break free from corporate capture, individuals must take protective measures into their own hands. Supporting organic food production, filtering drinking water and choosing natural products over chemical-laden alternatives represent practical steps toward reducing toxic burden.
The question remains whether government institutions will act on this evidence or continue prioritizing industry profits over public health—a choice that has consequences measured in lives lost to preventable disease.
Sources for this article include: